Rain Oncology Inc
Change company Symbol lookup
Select an option...
RAIN Rain Oncology Inc
EQT EQT Corp
NIO NIO Inc
EWA iShares MSCI Australia ETF
WDAY Workday Inc
BNOX Bionomics Ltd
NRDY Nerdy Inc
KEY KeyCorp
AMPX Amprius Technologies Inc
TPC Tutor Perini Corp
Go

Health Care : Pharmaceuticals | Small Cap Value

Rain Oncology Inc. is a late-stage precision oncology company. The Company is focused on developing therapies that target oncogenic drivers to genetically select patients. Its product candidate includes milademetan. Milademetan is an oral, small molecule inhibitor of the p53-mouse double minute 2 (p53-MDM2) complex that reactivates p53. The product candidate is being developed in patients with MDM2-dependent cancers. p53 acts as a regulator of various cellular processes. The activity of p53 is controlled and regulated by the inhibitory protein MDM2. MDM2 binds to p53, thereby inducing degradation and allowing normal cells to function properly. Milademetan, by binding MDM2 at the p53 interaction site, prevents the formation of the MDM2-p53 complex, allowing p53 reactivation and subsequent transcription of genes that trigger cancer cell cycle arrest or apoptosis and can be readily measured by increases in the pharmacodynamic marker MIC-1 (GDF15) in the blood.

Closing Price: $0.8546

Day's Change: 0.00 (0.00%)

Bid: --

Ask: --

B/A Size: --

Day's High: --

Day's Low: --

Volume (Light) Volume: 48,082 10-day average volume: 123,080: 48,082

September 12, 2023
9:24 am ET	Final Deadline for Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit! NEW YORK, NY / ACCESSWIRE / September 12, 2023 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or "the Company")...(Accesswire)
9:20 am ET	SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit NEW YORK, NY / ACCESSWIRE / September 12, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:(Accesswire)
9:01 am ET	Final Deadline for Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit New York, New York--(Newsfile Corp. - September 12, 2023) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or "the Company")...(Newsfile)
8:26 am ET	SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit NEW YORK, NY / ACCESSWIRE / September 12, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:(Accesswire)
8:05 am ET	Final Deadline for Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit! NEW YORK, NY / ACCESSWIRE / September 12, 2023 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or "the Company")...(Accesswire)
5:45 am ET	SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN) The Gross Law Firm issues the following notice to shareholders ofRain Oncology Inc.. Shareholders who purchased shares of RAIN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment...(PR Newswire)
September 11, 2023
11:32 pm ET	SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:(Accesswire)
10:53 pm ET	ROSEN, A TOP RANKED LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg WHY:Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19, 2023, both dates inclusive (the...(PR Newswire)
6:01 pm ET	SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:(Accesswire)
5:37 pm ET	Rain Oncology Inc: Please contact the Portnoy Law Firm to recover your losses; September 12, 2023 deadline.(Globe Newswire)
12:33 pm ET	SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:(Accesswire)
12:10 pm ET	SHAREHOLDER ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. (RAIN) Investors of a Class Action Lawsuit and Upcoming Deadline(Globe Newswire)
12:00 pm ET	The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN) The Law Offices of Frank R. Cruz reminds investors of the upcoming September 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN)...(BusinessWire)
11:49 am ET	SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:(Accesswire)
11:05 am ET	DEADLINE ALERT for BAX, RAIN, PTRA, and SE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders(Globe Newswire)
5:45 am ET	SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Rain Investors of a Lead Plaintiff Deadline of September 12, 2023 Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between July 20, 2021 and May 19, 2023. (PR Newswire)
September 10, 2023
10:00 am ET	SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit NEW YORK, NY / ACCESSWIRE / September 10, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:(Accesswire)
9:31 am ET	SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit NEW YORK, NY / ACCESSWIRE / September 10, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:(Accesswire)
8:50 am ET	Upcoming Deadline for Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman LLC to Actively Participate in the Class Action Lawsuit NEW YORK, NY / ACCESSWIRE / September 10, 2023 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or "the Company")...(Accesswire)
7:32 am ET	SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit NEW YORK, NY / ACCESSWIRE / September 10, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:(Accesswire)
Next >

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and